These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31056759)

  • 1. Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators.
    Kawamura M; Arai S; Yoshikawa K; Gokan T; Ogawa K; Ochi A; Onishi Y; Munetsugu Y; Ito H; Onuki T; Kobayashi Y; Shinke T
    Clin Cardiol; 2019 Jul; 42(7):670-677. PubMed ID: 31056759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes.
    Hyman MC; Bao H; Curtis JP; Minges K; Schaller RD; Birgersdotter-Green U; Marchlinski FE; Hsu JC
    Heart Rhythm; 2020 Nov; 17(11):1878-1886. PubMed ID: 32497762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
    J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.
    Biton Y; Goldenberg I; Kutyifa V; Baman JR; Solomon S; Moss AJ; Szepietowska B; McNitt S; Polonsky B; Zareba W; Barsheshet A
    J Am Coll Cardiol; 2016 Jan; 67(3):303-12. PubMed ID: 26796396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repolarization heterogeneity in patients with cardiac resynchronization therapy and its relation to ventricular tachyarrhythmias.
    Cvijić M; Antolič B; Klemen L; Zupan I
    Heart Rhythm; 2018 Dec; 15(12):1784-1790. PubMed ID: 29908369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
    Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
    Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.
    Manfredi JA; Al-Khatib SM; Shaw LK; Thomas L; Fogel RI; Padanilam B; Rardon D; Vatthyam R; Gemma LW; Golden K; Prystowsky EN
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):257-64. PubMed ID: 23443618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis.
    Deif B; Ballantyne B; Almehmadi F; Mikhail M; McIntyre WF; Manlucu J; Yee R; Sapp JL; Roberts JD; Healey JS; Leong-Sit P; Tang AS
    Cardiovasc Res; 2018 Sep; 114(11):1435-1444. PubMed ID: 30010807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyssynchrony and the risk of ventricular arrhythmias.
    Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade.
    Kantharia BK; Patel JA; Nagra BS; Ledley GS
    Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Continued Cardiac Resynchronization Therapy on Ventricular Arrhythmias After Left Ventricular Assist Device Implantation.
    Schleifer JW; Mookadam F; Kransdorf EP; Nanda U; Adams JC; Cha S; Pajaro OE; Steidley DE; Scott RL; Carvajal T; Saadiq RA; Srivathsan K
    Am J Cardiol; 2016 Aug; 118(4):556-9. PubMed ID: 27328958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
    Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
    Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.